A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy

Clinical trial NCT01611051 · COMPLETED

Trial details

NCT number: NCT01611051
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Neutropenia Febrile Neutropenia

Start date: 2012-03-01
Primary completion: 2013-01-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.